期刊文献+

肝癌肝移植术后受体预后相关因素的研究进展(英文) 被引量:1

Advances in predicting the prognosis of hepatocellular carcinoma recipients after liver transplantation
原文传递
导出
摘要 研究肝癌肝移植患者术后生存与影响生存的各影响因素之间的关系,并评价各影响因素及移植标准的价值。筛选有效的预测肝癌预后的影响因素,可帮助建立肝移植术后肿瘤预后预警机制,对改善肝癌肝移植受体的术后预后具有重要意义。杭州标准是被国际移植学界广泛接受的肝癌肝移植标准,在引领肝癌肝移植领域的发展中做出了重要贡献。 Hepatocellular carcinoma(HCC) is one of the most prevalent malignant tumors worldwide. Liver transplantation(LT) is known as a curative and therapeutic modality. However, the survival rates of recipients after LT are still not good enough because of tumor recurrence. To improve the survival rates of recipients after LT, identifying predictive factors for prognosis after LT and establishing a model assessing prognosis are very important to HCC patients. There has recently been a lot of clinical and basic research on recurrence and prognosis after LT. Progress has been made, especially in selection criteria for LT recipients and risk factors for predicting prognosis after LT. Hangzhou criteria, in line with China's high current incidence rate of primary liver, are first proposed by Chinese scholars of LT, and are accepted world-wide, and make an important contribution to the development of LT.
出处 《Journal of Zhejiang University-Science B(Biomedicine & Biotechnology)》 SCIE CAS CSCD 2018年第7期497-504,共8页 浙江大学学报(英文版)B辑(生物医学与生物技术)
基金 Project supported by the National Natural Science Foundation of China(No.81121002) the National S&T Major Project of China(No.2012ZX10002017)
关键词 肝癌 肝移植 复发 危险因子 预后 Hepatocellular carcinoma Liver transplantation Recurrence Risk factor Prognosis
  • 相关文献

参考文献1

二级参考文献11

  • 1Mazzaferro V,Regalia E,Doci R,et al.Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. New England Journal of Medicine, The . 1996
  • 2Yang ZF,Ho DW,Ng MN,Lau CK,Yu WC,Ngai P,Chu PW,Lam CT,Poon RT,Fan ST.Significance of CD90+ cancer stem cells in human liver cancer. Cancer Cell . 2008
  • 3S ugawara Y,Tamura S,Makuuchi M.Living donor liver transplantation for hepatocellular carcinoma: Tokyo University series. Digestive Diseases and Sciences . 2007
  • 4L iu CL,Fan ST,Cheung ST,Lo CM,Ng IO,Wong J.Anterior approach versus conventional approach right hepatic resection for large hepatocellular carcinoma: a prospective randomized controlled study. Annals of Surgery . 2006
  • 5M an K,Ng KT,Lo CM,Ho JW,Sun BS,Sun CK, et al.Ischemia-reperfusion of small liver remnant promotes liver tumor growth and metastases--activation of cell invasion and migration pathways. Liver Transplantation . 2007
  • 6C heung ST,Fan ST,Lee YT,Chow JP,Ng IO,Fong DY, et al.Albumin mRNA in plasma predicts post-transplant recurrence of patients with hepatocellular carcinoma. Transplantation . 2008
  • 7D uffy JP,Vardanian A,Benjamin E,Watson M,Farmer DG,Ghobrial RM, et al.Liver transplantation criteria for hepatocellular carcinoma should be expanded: a22-year experience with 467 patients at UCLA. Annals of Surgery . 2007
  • 8Z heng SS,Xu X,Wu J,Chen J,Wang WL,Zhang M, et al.Liver transplantation for hepatocellular carcinoma: Hangzhou experiences. Transplantation .
  • 9Y ao FY,Ferrell L,Bass NM,Bacchetti P,Ascher NL,Roberts JP.Liver transplantation for hepatocellular carcinoma: comparison of the proposed UCSF criteria with the Milan criteria and the Pittsburgh modified TNM criteria. Liver Transplantation . 2002
  • 10I to T,Takada Y,Ueda M,Haga H,Maetani Y,Oike F, et al.Expansion of selection criteria for patients with hepatocellular carcinoma in living donor liver transplantation. Liver Transpl 2007 .

共引文献7

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部